期刊
ANNALS OF PHYSICAL AND REHABILITATION MEDICINE
卷 59, 期 5-6, 页码 333-339出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.rehab.2016.07.004
关键词
Synovial joint; Articular cartilage; Synovium; Osteoarthritis (OA); Pathophysiology; Physical Activity; Physical Rehabilitation
资金
- European Commission
- Arthritis Research UK [20194]
- European Commission Framework 7 programme (EU FP7) [HEALTH.2012.2.4.5-2, 305815]
- European Commission's Innovative Medicines Initiative (IMI)
- Innovative Medicines Initiative (IMI) Joint Undertaking [115770]
- European Union's Seventh Framework programme
- Deanship of Scientific Research (DSR), King Abdulaziz University [1-141/1434 HiCi]
Introduction: Osteoarthritis (OA) is one of the most common forms of arthritis. There is accumulating evidence to suggest that OA is an inflammatory disease of the entire synovial joint and has multiple phenotypes. This presents the OA research community with new challenges and opportunities. The main challenge is to understand the root cause of the disease and identify differences and similarities between OA phenotypes. The key opportunity is the possibility of developing personalized and individualized prevention and treatment strategies for OA patients with different phenotypes of the disease. Indeed, it has been suggested that this is the era of 'personalized prevention' for OA. The aim of this mini-review paper is to focus on the pathophysiological aspects of OA development and progression, review the current concepts and discuss the future of personalized medicine for OA. Method: The PubMed/MEDLINE bibliographic database was searched using the keywords 'pathophysiology' and 'osteoarthritis'. Results: The PubMed/MEDLINE search yielded more than 12,000 relevant papers. A selection of these papers is reviewed here. Conclusion: There has been slow but steady progress in our understanding of the pathophysiology of OA over the last two decades. However, large gaps remain in our knowledge of OA pathogenesis and this impacts negatively on patients and drug development pipeline. In the absence of new pharmaceutical agents and disease modifying osteoarthritis drugs (DMOADs) it is clear that lifestyle modification and physical activity are important and may delay the need for surgical intervention. (C) 2016 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据